Google
RVMD — REVOLUTION MEDICINES INC (Healthcare >> Biotechnology)
RVMD FAQ
What is RVMD's ROE?
REVOLUTION MEDICINES INC reports a Return on Equity (ROE) of -91.45%.
What is RVMD's dividend yield?
REVOLUTION MEDICINES INC offers a dividend yield of 0.00%.
What is RVMD's Deepscope Quality Score?
Deepscope rates RVMD's overall financial quality at 15 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy RVMD?
Deepscope's AI Timing Score for RVMD is 87 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does RVMD belong to?
REVOLUTION MEDICINES INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 155.99
Price
4.68
(3.09%)
Day Change
|
|
|---|
RVMD, ファンダメンタルスコアはnot good ( ファンダメンタル = 15) but テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
ROEが昨年度比で低い
ROAがROEに比べて低い
Last-year ROA is lower than last-2-years ROA.
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not quite good , and ability to make profit is not good , ...
| Deepscope 分析 |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 50 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 155.99 |
| PBV / Sector |
21.45 / 4.48
|
| Earning Per Share | -6.65 |
| PE / Sector |
N/A / 16.68
|
| PEG or PE/Growth / Sector |
N/A / 0.53
|
| Average 1M Daily Value |
393.76 M
GREAT
|
| Average 1W Daily Value |
661.17 M
|
| Timing Factors |
|
57% |
| Financial Health |
|
50% |
| ポイントになる統計 |
|
47% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-06-04 09:23:59 |
| Symbol | RVMD |
| Name | REVOLUTION MEDICINES INC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 212.60 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 32,167.97 / 8,483.11 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 700 Saginaw Drive, Redwood City, CA, United States, 94063
Phone: 650 481 6801
Website: https://www.revmed.com
Employees: 883
Sector: Healthcare >> Biotechnology
Description: Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291) which is in early clinical development for the treatment of solid tumors, and zoldonrasib G12D (RMC-9805), which are in phase 3 registrational trial evaluating the combination of daraxonrasib with zoldonrasib in patients with 1L PDAC; and development candidates comprise RMC-5127 (G12V) which is in clinical trial, RMC-0708 (Q61H), that is in clinical trial; and RMC-8839 (G13C). Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
